Cargando…

Antiviral Resistance in Influenza Viruses: Clinical and Epidemiological Aspects

Two classes of anti-viral agents, the M2 ion channel inhibitors (amantadine, rimantadine) and neuraminidase (NA) inhibitors (oseltamivir, zanamivir) are available for treatment and prevention of infl uenza in most countries of the world. The principle concerns about emergence of antiviral resistance...

Descripción completa

Detalles Bibliográficos
Autor principal:	Hayden, Frederick G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2009
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7122859/ http://dx.doi.org/10.1007/978-1-60327-595-8_23

Ejemplares similares

Antiviral Resistance in Influenza Viruses: Clinical and Epidemiological Aspects
por: van der Vries, Erhard, et al.
Publicado: (2016)

Advances in antivirals for non‐influenza respiratory virus infections
por: Hayden, Frederick G.
Publicado: (2013)

Influenza virus and rhinovirus-related otitis media: potential for antiviral intervention
por: Hayden, Frederick G.
Publicado: (2000)

Antiviral combinations for severe influenza
por: Dunning, Jake, et al.
Publicado: (2014)

Influenza viruses – antiviral therapy and resistance
por: Duwe, Susanne
Publicado: (2017)

Antiviral Agents Against Respiratory Viruses
por: Ison, Michael G., et al.
Publicado: (2017)

Influenza virus polymerase inhibitors in clinical development
por: Hayden, Frederick G., et al.
Publicado: (2019)

Reducing Influenza Virus Transmission: The Potential Value of Antiviral Treatment
por: Hayden, Frederick G, et al.
Publicado: (2021)

Clinical Implications of Antiviral Resistance in Influenza
por: Li, Timothy C. M., et al.
Publicado: (2015)

Clinical applications of antiviral agents for chemophrophylaxis and therapy of respiratory viral infections
por: Hayden, Frederick G.
Publicado: (1985)

Neurologic aspects of influenza viruses
por: Davis, Larry E., et al.
Publicado: (2014)

Influenza and antiviral resistance: an overview
por: Lampejo, Temi
Publicado: (2020)

INFLUENZA VIRUS SURVEILLANCE BY THE INSTITUTO ADOLFO LUTZ, INFLUENZA SEASON 2014: ANTIVIRAL RESISTANCE
por: Santos, Katia Corrêa de Oliveira, et al.
Publicado: (2015)

Detection of oseltamivir‐resistant zoonotic and animal influenza A viruses using the rapid influenza antiviral resistance test
por: Hodges, Erin N., et al.
Publicado: (2019)

Prolonged Influenza Virus Shedding and Emergence of Antiviral Resistance in Immunocompromised Patients and Ferrets
por: van der Vries, Erhard, et al.
Publicado: (2013)

Antiviral resistance markers in influenza virus sequences in Mexico, 2000–2017
por: Toledo-Rueda, William, et al.
Publicado: (2018)

Antivirals Targeting the Surface Glycoproteins of Influenza Virus: Mechanisms of Action and Resistance
por: Bai, Yaqin, et al.
Publicado: (2021)

Antiviral Resistance and the Control of Pandemic Influenza
por: Lipsitch, Marc, et al.
Publicado: (2007)

Antiviral Response in Pandemic Influenza Viruses
por: García-Sastre, Adolfo
Publicado: (2006)

Editorial Commentary: Host and Viral Factors in Emergent Influenza Virus Infections
por: Hui, David S., et al.
Publicado: (2014)

Epidemiological consequences of household-based antiviral prophylaxis for pandemic influenza
por: Black, Andrew J., et al.
Publicado: (2013)

Drug resistance in influenza A virus: the epidemiology and management
por: Hussain, Mazhar, et al.
Publicado: (2017)

Epidemiology and Clinical Characteristics of Influenza C Virus
por: Sederdahl, Bethany K., et al.
Publicado: (2020)

A review of the epidemiological and clinical aspects of West Nile virus
por: Gray, Timothy J, et al.
Publicado: (2014)

648. Baloxavir Resistance: qPCR Detection of Antiviral Resistance Markers in Influenza A Virus
por: Tyler, Aaron J, et al.
Publicado: (2019)

The Epidemiological and Molecular Aspects of Influenza H5N1 Viruses at the Human-Animal Interface in Egypt
por: Kayali, Ghazi, et al.
Publicado: (2011)

Assessing the fitness of a dual-antiviral drug resistant human influenza virus in the ferret model
por: Stannard, Harry L., et al.
Publicado: (2022)

Antiviral Chemotherapyand Prophylaxis of Viral Respiratory Disease
por: Sperber, Steven J., et al.
Publicado: (1987)

Molecular Epidemiology and Baseline Resistance of Hepatitis C Virus to Direct Acting Antivirals in Croatia
por: Simicic, Petra, et al.
Publicado: (2022)

Epidemiological aspects of antibiotic resistance in respiratory pathogens
por: Mlynarczyk, G, et al.
Publicado: (2001)

1645. Exploring Clinical and Antiviral Efficacy of Baloxavir Marboxil in a Phase 3, Randomized, Double-Blind, Placebo- and Active-Controlled Study of Otherwise Healthy Adults/Adolescents in Seasonal Influenza: Impact on Regional Participants, Treatment Time and Influenza Type B Virus Infection (CAPSTONE-1 Study)
por: Kawaguchi, Keiko, et al.
Publicado: (2018)

Oropouche Virus: Clinical, Epidemiological, and Molecular Aspects of a Neglected Orthobunyavirus
por: Travassos da Rosa, Jorge Fernando, et al.
Publicado: (2017)

Osteoporosis: epidemiology, clinical and biological aspects
por: Reda, A, et al.
Publicado: (2010)

Antiviral agents active against influenza A viruses
por: De Clercq, Erik
Publicado: (2006)

Antiviral Drugs for Influenza and Other Respiratory Virus Infections
por: Aoki, Fred Y.
Publicado: (2015)

Antiviral activity of Jinchai capsule against influenza virus
por: Zhong, Juying, et al.
Publicado: (2013)

Can We “Hedge” against the Development of Antiviral Resistance among Pandemic Influenza Viruses?
por: Shay, David K., et al.
Publicado: (2009)

Antiviral Strategies for Emerging Influenza Viruses in Remote Communities
por: Laskowski, Marek, et al.
Publicado: (2014)

Antiviral monotherapy for hospitalised patients with COVID-19 is not enough
por: Cao, Bin, et al.
Publicado: (2020)

Influenza A detection, typing and assessment of antiviral resistance
por: Wong, S., et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_ue2hb6j3nqa6i34bfhs8sn2hdi